Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
35 Leser
Artikel bewerten:
(0)

Thermo Fisher Scientific Introduces Safer, Cleaner Method to Test Swine Carcasses for Trichinella

- A safer alternative to the current pepsin digestion method

SCHLIEREN, Switzerland, July 16, 2015 /PRNewswire/ -- Abattoirs and meat packers have a cleaner, safer way to test swine carcasses for potentially dangerous Trichinella at meat inspection - new PrioCHECK' Trichinella AAD from Thermo Fisher Scientific. The alternative artificial digestion (AAD) method has been validated and approved by the European Union and is now listed in commission regulation (EC) 2075/2005.

"Monitoring the health of animals at harvest helps determine a precursor for food safety," said Martin Guillet, global head and general manager of animal health at Thermo Fisher Scientific. "Testing for Trichinella at inspection is considered as an essential way to prevent zoonosis. Our solution contributes to this type of testing, helping to ensure the safety of the food source, and is in line with the Thermo Fisher Scientific mission of enabling customers to make the world healthier, cleaner and safer. "

PrioCHECK Trichinella AAD is a reliable alternative to the currently used pepsin-based artificial digestion method, because the test uses a recombinantly produced enzyme from a standardized and secured production facility, ensuring good availability of the enzyme and consistent quality. In addition, it does not use pepsin powder or hydrochloric acid, increasing ease of handling and worker safety.

Extensively validated by the CRL
The Community Reference Laboratory (CRL) for Trichinella in Rome has extensively validated the performance of the PrioCHECK Trichinella AAD Kit and has approved the product as an official method for use in the in vitro detection of Trichinella spp. in meat of domestic swine.

Testing methodology
Laboratories do not have to change their testing routine since the protocol of the sample preparation method follows the same steps as that of the currently used pepsin-based method. A piece of muscle tissue is chopped, minced and then digested with digestive enzymes. In the case of PrioCHECK Trichinella AAD, this enzyme is a subtilisin. The digestion solution is filtered, and after sedimentation steps, examined by microscope for the presence of the larvae. All components of the PrioCHECK Trichinella AAD are liquid solutions, and no acid is to be added. Therefore, the risks associated with handling powder or concentrated acids are avoided.

Trichinellosis
Trichinellosis is a zoonotic disease (can be transmitted from animals to humans) that occurs worldwide and is caused by the larvae of the nematode (roundworm) Trichinella. Humans can be infected by eating raw or insufficiently cooked meat. Under the European Commission (EC) Directive No. 2075/2005, all pigs slaughtered for human consumption have to be tested for Trichinella spp. by artificial digestion.

For more information about PrioCHECK Trichinella AAD, please visit www.thermofisher.com/animalhealth.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our four premier brands - Thermo Scientific, Life Technologies, Fisher Scientific and Unity Lab Services - we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

Media Contact Information
Dean Loftis
dloftis@mccormickcompany.com
903-564-6545

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.